Compare

Rollins/$ROL

1D1W1M3M6MYTD1Y5YMAX

About Rollins

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.
Ticker
$ROL
Sector
Business services
Primary listing
NYSE
Employees
21,946

Rollins Metrics

BasicAdvanced
$16B
29.66
$1.10
0.75
$0.73
2.24%

What the Analysts think about Rollins

Analyst ratings (Buy, Hold, Sell) for Rollins stock.
Analyst projections of the future price of Rollins stock.

Bulls say / Bears say

Q2 revenue grew 8.6% in commercial pest control and 10.5% in termite and ancillary services, helping offset softer residential demand. Growth across these service lines gives Rollins more than one engine for expansion. (Rollins)
Rollins targets 2% to 3% annual growth from acquisitions in a fragmented market estimated at more than $20 billion. This deal pipeline offers a further route to growth alongside its own customer demand. (Rollins)
Rollins generated $166 million in free cash flow in Q2, while paying $88 million in dividends and investing $117 million in acquisitions. That cash generation supports shareholder returns and gives it room to fund growth despite near-term trading pressure. (Rollins)
Lower lead volumes in some residential brands pulled Q2 organic growth to 5.7%, and Rollins cut its 2026 organic-growth outlook to at least 6% from 7% to 8%. Wells Fargo also warned that weaker consumer demand could persist, citing possible competition and changing search behaviour. (Rollins, CNBC)
Q2 operating margin fell 110 basis points as weaker-than-expected volume, higher medical costs and fuel expenses weighed on results. Operating income rose just 1.5% against 7.9% revenue growth, making the company’s reduced 10% incremental-margin target a key execution test. (Rollins)
Analysts have warned that AI-driven search could steer customers towards smaller local providers, while private-equity investment may intensify competition. If these shifts persist, they could make it harder for Rollins to restore organic growth in its consumer-led channels. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2026.

Rollins Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Rollins Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Rollins

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.